Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Conditions: Tuberculosis, Pulmonary; Tuberculosis Infection Interventions: Drug: Rifabutin; Drug: Delamanid; Drug: Bedaquiline; Drug: Moxifloxacin; Drug: Pyrazinamide; Drug: Isoniazid; Drug: Rifampin; Drug: Ethambutol Sponsors: Centers for Disease Control and Prevention; Tuberculosis Trials Consortium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials